Oct 13, 2026 08:01AM
Oct 13, 2026 08:00AM
Aug 6, 2026 08:15AM
Jul 27, 2026 06:46PM
Jul 27, 2026 06:45PM
May 15, 2026 08:00AM
May 15, 2026 08:00AM CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 8, 2026 08:30AM
Feb 27, 2026 08:30AM
Jan 14, 2026 09:00AM
Jan 9, 2026 08:30AM
Jan 9, 2026 08:30AM
Dec 22, 2025 07:06AM
Dec 5, 2025 08:30AM New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
Nov 26, 2025 07:01AM
Nov 26, 2025 07:00AM
Nov 25, 2025 04:05PM
Nov 14, 2025 08:00AM
Oct 24, 2025 08:29AM
Oct 8, 2025 05:35AM
Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
Sep 5, 2025 07:02AM
Sep 5, 2025 07:00AM
Sep 3, 2025 08:01AM
Sep 3, 2025 08:00AM
Aug 8, 2025 08:00AM
Jul 29, 2025 04:09PM
Jul 29, 2025 04:05PM Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
May 13, 2025 08:00AM
Apr 28, 2025 07:22AM
Apr 26, 2025 04:10PM
Apr 24, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 28, 2025 07:00AM
Mar 24, 2025 08:04AM CG Oncology (CGON) Announces Cretostimogene Grenadenorepvec Data Continued to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Mar 24, 2025 08:00AM
Mar 12, 2025 08:00AM
Dec 5, 2024 07:00AM
Dec 2, 2024 08:00AM
Nov 20, 2024 08:00AM
Nov 12, 2024 08:00AM
Nov 11, 2024 08:00AM CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder Cancer
Oct 21, 2024 06:06AM
Sep 26, 2024 10:45AM
Aug 8, 2024 08:23AM
Jun 18, 2024 08:00AM
Jun 6, 2024 12:15PM
Jun 6, 2024 12:14PM
May 24, 2024 08:00AM CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Me
May 3, 2024 11:23AM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All